![]() |
市場調查報告書
商品編碼
1383314
到 2030 年常溫凝膠滲透色譜市場預測:按類型、技術、應用、最終用戶和地區進行的全球分析Ambient Temperature Gel Permeation Chromatography Market Forecasts to 2030 - Global Analysis By Type, By Technology, Application, End User and By Geography |
根據 Stratistics MRC 的數據,預測期內常溫凝膠滲透色譜的全球市場將以 8.5% 的年複合成長率成長。
常溫凝膠滲透色譜 (GPC) 是化學和聚合物科學中使用的一種分析技術,用於根據分子大小分離和表徵大分子,特別是聚合物。 GPC 在常溫溫度或室溫下進行。在 GPC 中,將樣品溶解在適當的溶劑中並透過填充多孔凝膠的色譜柱。大分子不能進入孔,因此較早洗脫,而較小的分子進入孔並較晚洗脫。這種分離可以檢測聚合物和大分子的分子量分佈和其他與尺寸相關的特性。
根據國際製藥製造商聯合會 2017 年的報告,研究型製藥和生技公司每年在全球研發投資約 1,490 億美元。
常溫凝膠滲透色譜 (GPC) 在生命科學領域的使用不斷增加是市場的一個突出促進因素。 GPC 在生物技術和製藥行業中非常有用,可用於表徵蛋白質、核酸和多醣體等生物分子。它能夠精確檢測生物分子的分子量分佈和尺寸分析,這對於藥物開發、品管和法規遵循至關重要。隨著生命科學領域的快速發展和創新,GPC 在生物分子分析中的作用變得越來越重要。因此,對GPC設備和服務的需求不斷增加,成為GPC市場擴大的重要驅動力。
高昂的初始設定成本是常溫凝膠滲透色譜 (GPC) 市場的主要抑制因素。建立 GPC 實驗室需要對色譜系統、色譜柱、檢測器和資料分析軟體等設備進行大量投資。這些成本可能會阻礙小型研究機構、研究所和預算有限的新興企業進入市場。此外,持續的維護、校準和消耗品也會增加經濟負擔。
生物技術需求的成長為常溫凝膠滲透色譜 (GPC) 市場帶來了巨大的機會。 GPC是表徵蛋白質、核酸和碳水化合物等生物分子的重要分析工具,是生物技術研究和藥物開發的核心。隨著藥物研發技術產業不斷擴大,包括在藥物發現、生物製藥和個人化醫療中的應用,對精確分子量檢測和尺寸分析的需求不斷增加,這使其成為生物技術研究和產品開發的重要組成部分。
來自替代分析技術的競爭對常溫凝膠滲透色譜 (GPC) 市場構成了重大威脅。儘管 GPC 對於表徵聚合物非常有用,但更新、更快、更通用的方法(例如質譜法和核磁共振波譜法)正在獲得關注。這些替代方案提供了更廣泛的應用,例如結構闡明和詳細的分子分析。因此,潛在用戶可能會選擇這些技術而不是 GPC,特別是在高通量環境中或需要更深入的分子理解時。這些方面進一步阻礙了市場的擴張。
COVID-19 的爆發對常溫凝膠滲透色譜市場產生了各種影響。最初,由於供應鏈和實驗室營運中斷而面臨挑戰,但由於與病毒相關的研究活動活性化,市場已經復甦。 GPC 在與疫苗開發和治療研究相關的生物分子表徵中發揮了重要作用。然而,由於非 COVID-19 相關計劃的資金減少以及封鎖期間實驗室准入受到限制,市場成長暫時放緩。整體而言,此次疫情凸顯了 GPC 在生命科學研究中的重要性,同時也凸顯了面對不可預見的情況時的復原力和適應性的必要性。
預計化學和生化公司將在預測期內主導市場。這項預測是由 GPC 在聚合物分析、生物分子表徵和材料科學中的關鍵作用所推動的,所有這些對於化學和生物化學工業都至關重要。此外,GPC 還可作為製藥、生物技術和其他領域評估分子量分佈並確保產品品質的基本工具。隨著化學和生化行業的不斷擴張以及對精密分析解決方案的需求的增加,化學和生化公司有望佔據最大的市場佔有率。
分析系統領域預計將顯著成長。這是由於對先進分析設備的需求不斷成長。分析系統在為聚合物分析、生物分子表徵和材料科學提供準確、高解析度的資料方面發揮關鍵作用。此外,隨著業界尋求對材料和產品更準確、更詳細的了解,對最先進的 GPC 設備、檢測器和資料分析軟體的需求至關重要。在各個領域對複雜 GPC 技術不斷成長的需求的推動下,專注於品管、研究和法律規章遵從性的分析系統有望實現顯著成長。
北美預計將主導常溫凝膠滲透色譜市場,這主要是由於該地區成熟的製藥、化學和生物技術產業。這些行業有嚴格的品管要求和積極的研發,因此 GPC 用於精確的聚合物分析和生物分子表徵。此外,GPC 在確保產品品質和安全方面的作用是關注法規合規性。此外,主要市場參與企業和先進技術基礎設施的存在進一步加強了北美的地位,並強調了其在分析科學領域的關鍵作用。
預計亞太地區常溫凝膠滲透色譜市場將出現良好成長。該地區製藥、生物技術和化學工業的擴張以及研發活動的增加,增加了聚合物分析和生物分子表徵中對 GPC 的需求。此外,隨著亞太地區經濟的持續成長,人們越來越重視品管和法規合規性。快速成長的生物製藥產業和對技術進步的關注也增強了該地區的吸引力。隨著對精密分析解決方案的需求增加,亞太地區預計將出現成長,凸顯該地區在市場中的重要性。
According to Stratistics MRC, the Global Ambient Temperature Gel Permeation Chromatography Market is growing at a CAGR of 8.5% during the forecast period. Ambient Temperature Gel Permeation Chromatography (GPC) is an analytical technique used in chemistry and polymer science to separate and characterize macromolecules, particularly polymers, based on their molecular size. GPC is performed at ambient or room temperature. In GPC, a sample is dissolved in a suitable solvent and then passed through a column filled with a porous gel. Larger molecules cannot enter the pores and therefore elute more quickly, while smaller molecules enter the pores and elute later. This separation allows for the determination of molecular weight distribution and other size-related properties of polymers and macromolecules.
According to a report in 2017 by International Federation of Pharmaceutical Manufacturers and Associations, research based pharmaceutical and biotech companies annually invest around US$ 149 billion on research and development around world.
The increased use of ambient temperature gel permeation chromatography (GPC) in life sciences serves as a prominent driver for the market. GPC is invaluable in the biotechnology and pharmaceutical industries for characterizing biomolecules, including proteins, nucleic acids, and polysaccharides. It enables the precise determination of molecular weight distributions and the analysis of biomolecule size, essential for drug development, quality control, and regulatory compliance. As the life sciences sector experiences rapid growth and innovation, GPC's role in biomolecule analysis becomes increasingly significant. This, in turn, propels the demand for GPC instruments and services, making it a pivotal driver in the GPC market's expansion.
The high initial setup costs present a significant restraint in the ambient temperature gel permeation chromatography (GPC) market. Establishing a GPC laboratory requires a substantial investment in equipment, including chromatography systems, columns, detectors, and data analysis software. These expenses can deter smaller research institutions, laboratories, or startups with limited budgets from entering the market. Furthermore, ongoing maintenance, calibration, and consumables add to the financial burden.
The rising demand in biotechnology presents a significant opportunity for the ambient temperature gel permeation chromatography (GPC) market. GPC is a vital analytical tool for characterizing biomolecules, including proteins, nucleic acids, and carbohydrates, which are central to biotechnological research and pharmaceutical development. As the biotechnology industry continues to expand, with applications in drug discovery, biopharmaceuticals, and personalized medicine, there is a growing need for precise molecular weight determination and size analysis, making it an essential component in biotechnological research and product development.
Competition from alternative analytical techniques poses a significant threat to the ambient temperature gel permeation chromatography (GPC) market. While GPC is valuable for polymer characterization, newer, faster, and more versatile analytical methods, such as mass spectrometry and nuclear magnetic resonance spectroscopy, have gained prominence. These alternatives offer a broader range of applications, including structural elucidation and detailed molecular analysis. As a result, potential users may opt for these techniques over GPC, especially in high-throughput settings or when a deeper molecular understanding is required. Such aspects further hinder market expansion.
The COVID-19 pandemic has had a mixed impact on the ambient-temperature gel permeation chromatography market. While initial disruptions in supply chains and laboratory operations posed challenges, the market rebounded due to increased research activities related to the virus. GPC played a crucial role in characterizing biomolecules relevant to vaccine development and therapeutic research. However, reduced funding for non-COVID-19-related projects and limited access to laboratories during lockdowns temporarily slowed market growth. Overall, the pandemic underscored the importance of GPC in life sciences research but also highlighted the need for resilience and adaptability in the face of unforeseen disruptions.
The chemical and biochemical companies segment is expected to dominate the market during the forecast period. This projection is driven by the pivotal role of GPC in polymer analysis, biomolecule characterization, and material science, all of which are integral to the chemical and biochemical industries. Moreover, GPC serves as a fundamental tool for assessing molecular weight distribution and ensuring product quality in pharmaceuticals, biotechnology, and other sectors. With the continuous expansion of these industries and the growing need for precise analytical solutions, chemical and biochemical companies are poised to secure the largest market share.
The analytical systems segment is projected to experience substantial growth. This is due to the increasing demand for advanced analytical instrumentation. Analytical systems play a pivotal role in providing accurate and high-resolution data for polymer analysis, biomolecule characterization, and materials science. Furthermore, industries demand more precise and detailed insights into their materials and products, the need for cutting-edge GPC instruments, detectors, and data analysis software becomes crucial. With a focus on quality control, research, and regulatory compliance, the analytical systems is set to witness remarkable growth, driven by the rising demand for sophisticated GPC technology across various sectors.
North America is projected to dominate the Ambient Temperature Gel Permeation Chromatography market, primarily due to the region's well-established pharmaceutical, chemical, and biotechnology industries. The stringent quality control requirements and extensive research and development activities in these sectors drive the adoption of GPC for precise polymer analysis and biomolecule characterization. Additionally, a robust focus on regulatory compliance aligns with GPC's role in ensuring product quality and safety. Furthermore, the presence of key market players and advanced technological infrastructure further solidify North America's position emphasizing its pivotal role in the analytical sciences landscape.
The Asia Pacific region is poised to register lucrative growth in the ambient temperature gel permeation chromatography market. The region's expanding pharmaceutical, biotechnology, and chemical industries, along with increasing research and development activities, drive the demand for GPC in polymer analysis and biomolecule characterization. Additionally, as Asia Pacific economies continue to grow, there is a heightened emphasis on quality control and regulatory compliance. The presence of a burgeoning biopharmaceutical sector and a focus on technological advancements contribute to the region's attractiveness. As the need for precise analytical solutions rises, Asia Pacific is anticipated to experience growth, underscoring its significance in the market.
Some of the key players in Ambient Temperature Gel Permeation Chromatography Market include: Agilent Technologies, Gilson, Inc., J2 Scientific, LabAlliance, Labtech, Malvern Panalytical, Nittoseiko Analytech Co., Ltd, Polymer Char, PSS Polymer Standards Service, Schambeck SFD, Shimadzu Corporation, Tosoh Corporation, Waters Corporation and Wyatt Technology Corporation.
In September 2023, Laboratory Alliance opened its first Oneida County patient service center in September at 555 French Rd. in New Hartford, N.Y. Walk-in blood draw services are now available in four counties -Onondaga, Madison, Oswego and now Oneida.
In September 2023, Agilent Technologies Inc. recently signed a Research Collaboration Agreement (RCA) with the National Cancer Centre Singapore (NCCS) outlining their collaboration to accelerate translational cancer research on the genomic landscape of Asian-prevalent cancers over the next two years. The scope of the agreement includes the supply of an Agilent Magnis Next-Generation Sequencing (NGS) Preparation System to help investigate details specific to Asian cancer cohorts, where tissue samples derived from routine clinical care remain limited locally and regionally.